Shu Sherry T, Emert-Sedlak Lori A, Smithgall Thomas E
From the Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15219.
From the Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15219
J Biol Chem. 2017 Feb 17;292(7):2670-2678. doi: 10.1074/jbc.M116.770016. Epub 2016 Dec 28.
The HIV-1 Nef accessory factor enhances viral infectivity, immune evasion, and AIDS progression. Nef triggers rapid down-regulation of CD4 via the endocytic adaptor protein 2 (AP-2) complex, a process linked to enhanced viral infectivity and immune escape. Here, we describe a bimolecular fluorescence complementation (BiFC) assay to visualize the interaction of Nef with AP-2 and CD4 in living cells. Interacting protein pairs were fused to complementary non-fluorescent fragments of YFP and co-expressed in 293T cells. Nef interactions with both CD4 and AP-2 resulted in complementation of YFP and a bright fluorescent signal by confocal microcopy that localized to the cell periphery. Co-expression of the AP-2 α subunit enhanced the Nef·AP-2 σ2 subunit BiFC signal and vice versa, suggesting that the AP-2 α-σ2 hemicomplex interacts cooperatively with Nef. Mutagenesis of Nef amino acids Arg-134, Glu-174, and Asp-175, which stabilize Nef for AP-2 α-σ2 binding in a recent co-crystal structure, substantially reduced AP-2 interaction without affecting CD4 binding. A dimerization-defective mutant of Nef failed to interact with either CD4 or AP-2 in the BiFC assay, indicating that Nef quaternary structure is required for CD4 and AP-2 recruitment as well as CD4 down-regulation. A small molecule previously shown to bind the Nef dimerization interface also reduced Nef interactions with AP-2 and CD4 and restored CD4 expression to the surface of HIV-infected cells. Our findings provide a mechanistic explanation for previous observations that dimerization-defective Nef mutants fail to down-regulate CD4 and validate the Nef dimerization interface as a target site for antiretroviral drug development.
HIV-1 Nef辅助因子可增强病毒感染性、免疫逃逸能力及艾滋病进展。Nef通过内吞衔接蛋白2(AP-2)复合物触发CD4的快速下调,这一过程与增强病毒感染性和免疫逃逸相关。在此,我们描述了一种双分子荧光互补(BiFC)分析方法,用于在活细胞中可视化Nef与AP-2及CD4的相互作用。相互作用的蛋白对与黄色荧光蛋白(YFP)的互补非荧光片段融合,并在293T细胞中共表达。Nef与CD4和AP-2的相互作用均导致YFP互补,并通过共聚焦显微镜观察到定位于细胞周边的明亮荧光信号。AP-2 α亚基的共表达增强了Nef·AP-2 σ2亚基的BiFC信号,反之亦然,这表明AP-2 α-σ2半复合物与Nef协同相互作用。在最近的共晶体结构中稳定Nef与AP-2 α-σ2结合的Nef氨基酸残基Arg-134、Glu-174和Asp-175发生突变后,显著降低了与AP-2的相互作用,但不影响与CD4的结合。在BiFC分析中,Nef的二聚化缺陷突变体无法与CD4或AP-2相互作用,这表明Nef的四级结构对于CD4和AP-2的募集以及CD4的下调是必需的。先前显示能结合Nef二聚化界面的一种小分子也减少了Nef与AP-2和CD4的相互作用,并使CD4表达恢复到HIV感染细胞的表面。我们的研究结果为先前观察到的二聚化缺陷Nef突变体无法下调CD4提供了机制解释,并验证了Nef二聚化界面作为抗逆转录病毒药物开发的靶点。